Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 346 to 360 of 7686 results

  1. Antenatal care (NG201)

    This guideline covers the routine antenatal care that women and their babies should receive. It aims to ensure that pregnant women are offered regular check-ups, information and support. We have also published a guideline on postnatal care , which covers the topics of emotional attachment and baby feeding.

  2. Maternal and child nutrition (PH11)

    This guideline covers the nutrition of pregnant women, including women who are planning to become pregnant, mothers and other carers of children aged under 5 and their children. In particular, it aims to address disparities in the nutrition of low-income and other disadvantaged groups compared with the general population.

  3. Crizotinib for treating ROS1-positive advanced non-small-cell lung cancer (MA review of TA529) [ID6289]

    In development [GID-TA11450] Expected publication date: 04 December 2024

  4. Bevacizumab gamma for treating wet age-related macular degeneration [ID6320]

    In development [GID-TA11193] Expected publication date: 04 December 2024

  5. Meningitis (bacterial) and meningococcal disease update

    In development [GID-QS10181] Expected publication date: 04 December 2024

  6. Systemic lupus erythematosus

    All NICE products on systemic lupus erythematosus. Includes any guidance.

  7. Complications of cancer

    All NICE products on complications of cancer. Includes any guidance, advice and quality standards.

  8. Endometrial cancers

    All NICE products on endometrial cancers. Includes any guidance.

  9. Brain cancers

    All NICE products on brain cancers. Includes any guidance, advice and quality standards.

  10. Breast cancer

    All NICE products on breast cancer. Includes any guidance, advice and quality standards.

  11. Genomic biomarker-based cancer treatments

    All NICE products on genomic biomarker-based cancer treatments. Includes any guidance.

  12. Colorectal cancer

    All NICE products on colorectal cancer. Includes any guidance, advice and quality standards.

  13. Bladder cancer

    All NICE products on bladder cancer. Includes any guidance, advice and quality standards.

  14. Coeliac disease

    All NICE products on coeliac disease. Includes any guidance and quality standards.

  15. Cervical cancer

    All NICE products on cervical cancer. Includes any guidance and quality standards.